Combination of Curcumin and Metformin Inhibits Cell Growth and Induces Apoptosis without Affecting the Cell Cycle in LNCaP Prostate Cancer Cell Line

References

• Khazaei Z, Sohrabivafa M, Momenabadi V, Moayed L, Goodarzi E. Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide prostate cancers and their relationship with the human development index. Adv Hum Biol. 2019;9(3):245–250. doi:10.4103/2321-8568.262891
   Web of Science ®Google Scholar
• Chen F-Z, Zhao X-K. Prostate cancer: Current treatment and prevention strategies. Iran Red Crescent Med J. 2013;15(4):279–284. doi:10.5812/ircmj.6499
   PubMed Web of Science ®Google Scholar
• Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Barry MJ, Zietman A, O'Leary M, Walker-Corkery E, et al. Outcomes of localized prostate cancer following conservative management. JAMA. 2009;302(11):1202–1209. doi:10.1001/jama.2009.1348
   PubMed Web of Science ®Google Scholar
• Mongiat-Artus P, Peyromaure M, Richaud P, Droz J-P, Rainfray M, Jeandel C, Rebillard X, Moreau J-L, Davin J-L, Salomon L, et al.; Sous-Comité Prostate du CC-AFU. Recommendations for the treatment of prostate cancer in the elderly man: A study by the oncology committee of the French association of urology. Prog Urol. 2009;19(11):810–817. doi:10.1016/j.purol.2009.02.008
   PubMed Web of Science ®Google Scholar
• Crawford ED, Moul JW. ADT risks and side effects in advanced prostate cancer: Cardiovascular and acute renal injury. Oncology. 2015;29(1):55–66.
   PubMed Web of Science ®Google Scholar
• Chowdhury S, Kirby R. Advances in the treatment of metastatic prostate cancer. Practitioner 2013;257(1760):15–18.
   PubMedGoogle Scholar
• Crawford ED, Moul JW. ADT risks and side effects in advanced prostate cancer: Cardiovascular and acute renal injury. Oncology (Williston Park) 2015;29(1):55–58; 65–66.
   PubMed Web of Science ®Google Scholar
• Picard JC, Golshayan AR, Marshall DT, Opfermann KJ, Keane TE. The multi-disciplinary management of high-risk prostate cancer. Urol Oncol. 2012;30(1):3–15. doi:10.1016/j.urolonc.2009.09.002
   PubMed Web of Science ®Google Scholar
• Palmer AC, Sorger PK. Combination cancer therapy can confer benefit via patient-to-patient variability without drug additivity or synergy. Cell 2017;171(7):1678.e13–1691.e13. doi:10.1016/j.cell.2017.11.009
   Web of Science ®Google Scholar
• Nowak-Sliwinska P, Scapozza L, Ruiz IAA. Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer. Biochim Biophys Acta Rev Cancer 2019;1871(2):434–454. doi:10.1016/j.bbcan.2019.04.005
   PubMed Web of Science ®Google Scholar
• Bayat Mokhtari R, Homayouni TS, Baluch N, Morgatskaya E, Kumar S, Das B, Yeger H. Combination therapy in combating cancer. Oncotarget 2017;8(23):38022–38043. doi:10.18632/oncotarget.16723
   PubMed Web of Science ®Google Scholar
• Banerjee S, Singh SK, Chowdhury I, Lillard JW, Jr., Singh R. Combinatorial effect of curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancer. Front Biosci (Elite Ed). 2017;9:235–245. doi:10.2741/e798
   PubMedGoogle Scholar
• Rocha GZ, Dias MM, Ropelle ER, Osório-Costa F, Rossato FA, Vercesi AE, Saad MJA, Carvalheira JBC. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth. Clin Cancer Res. 2011;17(12):3993–4005. doi:10.1158/1078-0432.ccr-10-2243
   PubMed Web of Science ®Google Scholar
• Ramezani A, Haddad R, Sedaghati B, Jafari D. Effects of fungal extracts on vinblastine and vincristine production and their biosynthesis pathway genes in Catharanthus roseus. S Afr J Bot. 2018;119:163–171. doi:10.1016/j.sajb.2018.08.015
   Web of Science ®Google Scholar
• Dorai T, Aggarwal BB. Role of chemopreventive agents in cancer therapy. Cancer Lett. 2004;215(2):129–140. doi:10.1016/j.canlet.2004.07.013
   PubMed Web of Science ®Google Scholar
• Shehzad A, Lee J, Lee YS. Curcumin in various cancers. Biofactors 2013;39(1):56–68. doi:10.1002/biof.1068
   PubMed Web of Science ®Google Scholar
• Gupta SC, Kismali G, Aggarwal BB. Curcumin, a component of turmeric: from farm to pharmacy. Biofactors 2013;39(1):2–13. doi:10.1002/biof.1079
   PubMed Web of Science ®Google Scholar
• Scarpello JH, Howlett HC. Metformin therapy and clinical uses. Diab Vasc Dis Res. 2008;5(3):157–167. doi:10.3132/dvdr.2008.027
   PubMed Web of Science ®Google Scholar
• Wang Y-W, He S-J, Feng X, Cheng J, Luo Y-T, Tian L, Huang Q. Metformin: A review of its potential indications. Drug Des Dev Ther. 2017;11:2421–2429. doi:10.2147/DDDT.S141675
   PubMed Web of Science ®Google Scholar
• Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD. Metformin and reduced risk of cancer in diabetic patients. BMJ. 2005;330(7503):1304–1305. doi:10.1136/bmj.38415.708634.F7
   PubMed Web of Science ®Google Scholar
• Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res. 2006;66(21):10269–10273. doi:10.1158/0008-5472.CAN-06-1500
   PubMed Web of Science ®Google Scholar
• Buzzai M, Jones RG, Amaravadi RK, Lum JJ, DeBerardinis RJ, Zhao F, Viollet B, Thompson CB. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res. 2007;67(14):6745–6752. doi:10.1158/0008-5472.CAN-06-4447
   PubMed Web of Science ®Google Scholar
• Dowling RJ, Zakikhani M, Fantus IG, Pollak M, Sonenberg N. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res. 2007;67(22):10804–10812. doi:10.1158/0008-5472.CAN-07-2310
   PubMed Web of Science ®Google Scholar
• Isakovic A, Harhaji L, Stevanovic D, Markovic Z, Sumarac-Dumanovic M, Starcevic V, Micic D, Trajkovic V. Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis. Cell Mol Life Sci. 2007;64(10):1290–1302. doi:10.1007/s00018-007-7080-4
   PubMed Web of Science ®Google Scholar
• Gotlieb WH, Saumet J, Beauchamp M-C, Gu J, Lau S, Pollak MN, Bruchim I. In vitro metformin anti-neoplastic activity in epithelial ovarian cancer. Gynecol Oncol. 2008;110(2):246–250. doi:10.1016/j.ygyno.2008.04.008
   PubMed Web of Science ®Google Scholar
• Ben Sahra I, Laurent K, Loubat A, Giorgetti-Peraldi S, Colosetti P, Auberger P, Tanti JF, Le Marchand-Brustel Y, Bost F. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene. 2008;27(25):3576–3586. doi:10.1038/sj.onc.1211024
   PubMed Web of Science ®Google Scholar
• Liu B, Fan Z, Edgerton SM, Deng X-S, Alimova IN, Lind SE, Thor AD. Metformin induces unique biological and molecular responses in triple negative breast cancer cells. Cell Cycle 2009;8(13):2031–2040. doi:10.4161/cc.8.13.8814
   PubMed Web of Science ®Google Scholar
• Cantrell LA, Zhou C, Mendivil A, Malloy KM, Gehrig PA, Bae-Jump VL. Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy. Gynecol Oncol. 2010;116(1):92–98. doi:10.1016/j.ygyno.2009.09.024
   PubMed Web of Science ®Google Scholar
• Mohajeri M, Sadeghizadeh M, Najafi F, Javan M. Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair. Neuropharmacology 2015;99:156–167. doi:10.1016/j.neuropharm.2015.07.013
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang C, Bao J, Jia X, Liang Y, Wang X, Chen M, Su H, Li P, Wan J-B, et al. Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death. Sci Rep. 2016;6:26064. doi:10.1038/srep26064
   PubMed Web of Science ®Google Scholar
• Falah RR, Talib WH, Shbailat SJ. Combination of metformin and curcumin targets breast cancer in mice by angiogenesis inhibition, immune system modulation and induction of p53 independent apoptosis. Ther Adv Med Oncol. 2017;9(4):235–252. doi:10.1177/1758834016687482
   PubMed Web of Science ®Google Scholar
• Farajzadeh R, Pilehvar-Soltanahmadi Y, Dadashpour M, Javidfar S, Lotfi-Attari J, Sadeghzadeh H, Shafiei-Irannejad V, Zarghami N. Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells. Artif Cells Nanomed Biotechnol. 2018;46(5):917–925. doi:10.1080/21691401.2017.1347879
   PubMed Web of Science ®Google Scholar
• Li Y, Wang M, Zhi P, You J, Gao JQ. Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models. Oncotarget 2018;9(2):2158–2174. doi:10.18632/oncotarget.23187
   PubMedGoogle Scholar
• Zhang H-N, Yu C-X, Zhang P-J, Chen W-W, Jiang A-L, Kong F, Deng J-T, Zhang J-Y, Young CY. Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP. Acta Pharmacol Sin. 2007;28(3):423–430. doi:10.1111/j.1745-7254.2007.00501.x
   PubMed Web of Science ®Google Scholar
• Chen X, Li C, He T, Mao J, Li C, Lyu J, Meng QH. Metformin inhibits prostate cancer cell proliferation, migration, and tumor growth through upregulation of PEDF expression. Cancer Biol Ther. 2016;17(5):507–514. doi:10.1080/15384047.2016.1156273
   PubMed Web of Science ®Google Scholar
• Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27–55. doi:10.1016/0065-2571(84)90007-4
   PubMedGoogle Scholar
• Chou T. Relationships between inhibition constants and fractional inhibition in enzyme-catalyzed reactions with different numbers of reactants, different reaction mechanisms, and different types and mechanisms of inhibition. Mol Pharmacol. 1974;10(2):235–247.
   PubMed Web of Science ®Google Scholar
• Raisova M, Hossini AM, Eberle J, Riebeling C, Wieder T, Sturm I, Daniel PT, Orfanos CE, Geilen CC. The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J Invest Dermatol. 2001;117(2):333–340. doi:10.1046/j.0022-202x.2001.01409.x
   PubMed Web of Science ®Google Scholar
• Murad H, Hawat M, Ekhtiar A, AlJapawe A, Abbas A, Darwish H, Sbenati O, Ghannam A. Induction of G1-phase cell cycle arrest and apoptosis pathway in MDA-MB-231 human breast cancer cells by sulfated polysaccharide extracted from Laurencia papillosa. Cancer Cell Int. 2016;16:39. doi:10.1186/s12935-016-0315-4
   PubMed Web of Science ®Google Scholar
• Demain AL, Vaishnav P. Natural products for cancer chemotherapy. Microb Biotechnol. 2011;4(6):687–699. doi:10.1111/j.1751-7915.2010.00221.x
   PubMed Web of Science ®Google Scholar
• Seyed Hosseini E, Alizadeh Zarei M, Babashah S, Nakhaei Sistani R, Sadeghizadeh M, Haddad Kashani H, Amini Mahabadi J, Izadpanah F, Atlasi MA, Nikzad H, et al. Studies on combination of oxaliplatin and dendrosomal nanocurcumin on proliferation, apoptosis induction, and long non-coding RNA expression in ovarian cancer cells. Cell Biol Toxicol. 2019;35(3):247–266. doi:10.1007/s10565-018-09450-8
   PubMed Web of Science ®Google Scholar
• Alizadeh AM, Sadeghizadeh M, Najafi F, Ardestani SK, Erfani-Moghadam V, Khaniki M, Rezaei A, Zamani M, Khodayari S, Khodayari H, et al. Encapsulation of curcumin in diblock copolymer micelles for cancer therapy. BioMed Res Int. 2015;2015:1–824746. doi:10.1155/2015/824746
   Web of Science ®Google Scholar
• Al-Zaidan L, El Ruz RA, Malki AM. Screening novel molecular targets of metformin in breast cancer by proteomic approach. Front Public Health 2017;5:277–277. doi:10.3389/fpubh.2017.00277
   PubMed Web of Science ®Google Scholar
• Lindsay C, Kostiuk M, Conrad D, O’Connell DA, Harris J, Seikaly H, Biron VL. Antitumour effects of metformin and curcumin in human papillomavirus positive and negative head and neck cancer cells. Mol Carcinog. 2019;58(11):1946–1959. doi:10.1002/mc.23087
   PubMed Web of Science ®Google Scholar
• Zhu L, Han MB, Gao Y, Wang H, Dai L, Wen Y, Na LX. Curcumin triggers apoptosis via upregulation of Bax/Bcl-2 ratio and caspase activation in SW872 human adipocytes. Mol Med Rep. 2015;12(1):1151–1156. doi:10.3892/mmr.2015.3450
   PubMed Web of Science ®Google Scholar
• Ming L, Wang P, Bank A, Yu J, Zhang L. PUMA dissociates Bax and BCL-XL to induce apoptosis in colon cancer cells. J Biol Chem. 2006;281(23):16034–16042. doi:10.1074/jbc.M513587200
   PubMed Web of Science ®Google Scholar
• Yu J, Zhang L. PUMA, a potent killer with or without p53. Oncogene 2008;27(Suppl 1):S71–S83. doi:10.1038/onc.2009.45
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV, El‐Deiry WS. In vitro evaluation of a p53‐expressing adenovirus as an anti‐cancer drug. Int J Cancer 1996;67(3):386–392. doi:10.1002/(SICI)1097-0215(19960729)67:3<386::AID-IJC13>3.0.CO;2-6
   PubMed Web of Science ®Google Scholar
• Keshelava N, Zuo JJ, Waidyaratne NS, Triche TJ, Reynolds CP. p53 mutations and loss of p53 function confer multidrug resistance in neuroblastoma. Med Pediatr Oncol. 2000;35(6):563–568. doi:10.1002/1096-911X(20001201)35:6<563::AID-MPO15>3.0.CO;2-J
   PubMedGoogle Scholar
• Ecke TH, Schlechte HH, Hübsch A, Lenk SV, Schiemenz K, Rudolph BD, Miller K. TP53 mutation in prostate needle biopsies-comparison with patients follow-up. Anticancer Res. 2007;27(6):4143–4148.
   PubMed Web of Science ®Google Scholar
• Ge L, Shao W, Zhang Y, Qiu Y, Cui D, Huang D, Deng Z. RNAi targeting of hTERT gene expression induces apoptosis and inhibits the proliferation of lung cancer cells. Oncol Lett. 2011;2(6):1121–1129. doi:10.3892/ol.2011.388
   PubMed Web of Science ®Google Scholar
• Li Y, Pan G, Chen Y, Yang Q, Hao T, Zhao L, Zhao L, Cong Y, Diao A, Yu P, et al. Inhibitor of the human telomerase reverse trancriptase (hTERT) gene promoter induces cell apoptosis via a mitochondrial-dependent pathway. Eur J Med Chem. 2018;145:370–378. doi:10.1016/j.ejmech.2017.12.077
   PubMed Web of Science ®Google Scholar
• Ramachandran C, Fonseca HB, Jhabvala P, Escalon EA, Melnick SJ. Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line. Cancer Lett. 2002;184(1):1–6. doi:10.1016/s0304-3835(02)00192-1
   PubMed Web of Science ®Google Scholar
• Javidfar S, Pilehvar-Soltanahmadi Y, Farajzadeh R, Lotfi-Attari J, Shafiei-Irannejad V, Hashemi M, Zarghami N. The inhibitory effects of nano-encapsulated metformin on growth and hTERT expression in breast cancer cells. J Drug Delivery Sci Technol. 2018;43:19–26. doi:10.1016/j.jddst.2017.09.013
   Web of Science ®Google Scholar
• Zhong YQ, Xia ZS, Fu YR, Zhu ZH. Knockdown of hTERT by SiRNA suppresses growth of Capan-2 human pancreatic cancer cell via the inhibition of expressions of Bcl-2 and COX-2. J Digest Dis. 2010;11(3):176–184. doi:10.1111/j.1751-2980.2010.00433.x
   PubMed Web of Science ®Google Scholar
• Del Bufalo D, Rizzo A, Trisciuoglio D, Cardinali G, Torrisi MR, Zangemeister-Wittke U, Zupi G, Biroccio A. Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function. Cell Death Differ. 2005;12(11):1429–1438. doi:10.1038/sj.cdd.4401670
   PubMed Web of Science ®Google Scholar
• Hall MN. mTOR-what does it do?. Transplant Proc. 2008;40(10 Suppl):S5–S8. doi:10.1016/j.transproceed.2008.10.009
   PubMedGoogle Scholar
• Tian T, Li X, Zhang J. mTOR signaling in cancer and mTOR inhibitors in solid tumor targeting therapy. IJMS. 2019;20(3):755. doi:10.3390/ijms20030
   Google Scholar
• Wang Y, Xu W, Yan Z, Zhao W, Mi J, Li J, Yan H. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways. J Exp Clin Cancer Res. 2018;37(1):63. doi:10.1186/s13046-018-0731-5
   PubMed Web of Science ®Google Scholar
• Matsubara H, Sakakibara K, Kunimitsu T, Matsuoka H, Kato K, Oyachi N, Dobashi Y, Matsumoto M. Non-small cell lung carcinoma therapy using mTOR-siRNA. Int J Clin Exp Pathol. 2012;5(2):119–125.
   PubMed Web of Science ®Google Scholar
• Jafari D, Malih S, Eslami SS, Jafari R, Darzi L, Tarighi P, Samadikuchaksaraei A. The relationship between molecular content of mesenchymal stem cells derived exosomes and their potentials: Opening the way for exosomes based therapeutics. Biochimie 2019;165:76–89. doi:10.1016/j.biochi.2019.07.009
   PubMed Web of Science ®Google Scholar
• Davod J, Fatemeh DN, Honari H, Hosseini R. Constructing and transient expression of a gene cassette containing edible vaccine elements and shigellosis, anthrax and cholera recombinant antigens in tomato. Mol Biol Rep. 2018;45(6):2237–2210. doi:10.1007/s11033-018-4385-3
   PubMed Web of Science ®Google Scholar
• Jafari D, Dehghan NF. Isolation and bioinformatics study of TbJAMYC transcription factor involved in biosynthesis of Taxol from Iranian yew. Rangelands Forests Plant Breed Genet Res. 2018;26:12–22.
   Google Scholar
• Jafari D, Dehghan NF, Honari H, Hoseini R, Jafari R. Bioinformatic analysis of different fusions of ipaD, PA20 and CTxB antigens: A preliminary analysis for vaccine design. Genet 3rd Millennium 2016;14:4234–4241.
   Google Scholar
• Kalani A, Chaturvedi P. Curcumin-primed and curcumin-loaded exosomes: Potential neural therapy. Neural Regen Res. 2017;12(2):205–206. doi:10.4103/1673-5374.200799
   PubMed Web of Science ®Google Scholar